newsfilter
← Latest News
GlobeNewswire·

Evaxion concludes Annual General Meeting

COPENHAGEN, Denmark, April 16, 2026 - Evaxion A/S (NASDAQ:EVAX) ("Evaxion"), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, held its Annual General Meeting